HIV-1 Vpr disrupts the IFN-TET-ISG pathway to promote HIV-1 infection and persistence

$288,640R01FY2020AINIH

University Of Maryland Baltimore, Baltimore MD

Investigators

Lishan Sucontact

Linked publications, trials & patents

Paper 35325048 Paper 33767427 Paper 31431548 Paper 31420375 Paper 31310587 Paper 31055732 Paper 29883611

View original record on NIH RePORTER →